...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Traditional Japanese Medicine Daikenchuto Improves Functional Constipation in Poststroke Patients
【24h】

Traditional Japanese Medicine Daikenchuto Improves Functional Constipation in Poststroke Patients

机译：大日本传统药大kenchuto改善中风后患者的功能性便秘

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Poststroke patients with functional constipation, assessed by the Rome III criteria, from 6 hospitals were recruited in a study on the effects of the traditional Japanese medicine Daikenchuto (DKT) on constipation. Thirty-four patients (17 men and 17 women; mean age: 78.1 ± 11.6 years) were randomly assigned to 2 groups; all patients received conventional therapy for constipation, and patients in the DKT group received 15 g/day of DKT for 4 weeks. Constipation scoring system (CSS) points and the gas volume score (GVS) (the measure of the intestinal gas volume calculated from plain abdominal radiographs) were recorded before and after a 4-week observation period. The total score on the CSS improved significantly in the DKT group compared to the control (P < 0.01). In addition, scores for some CSS subcategories (frequency of bowel movements, feeling of incomplete evacuation, and need for enema/disimpaction) significantly improved in the DKT group (P < 0.01, P = 0.049, and P = 0.03, resp.). The GVS was also significantly reduced in the DKT group compared to the control (P = 0.03). DKT in addition to conventional therapy is effective in treating functional constipation in poststroke patients. This study was a randomized controlled trial and was registered in the UMIN Clinical Trial Registry (no. UMIN000007393).
机译：根据罗马III标准评估的6家医院的中风后功能性便秘患者被招募到一项研究中，研究了传统日药Daikenchuto（DKT）对便秘的影响。将34例患者（男17例，女17例;平均年龄：78.1±11.6岁）随机分为两组。所有患者均接受常规便秘治疗，DKT组患者每天接受15 g / d DKT，持续4周。在为期4周的观察前后，分别记录便秘评分系统（CSS）点和气体量得分（GVS）（根据腹部平片X线计算得出的肠道气体量）。与对照组相比，DKT组的CSS总分有显着提高（P <0.01）。此外，在DKT组中，某些CSS子类别的得分（排便频率，不完全排空的感觉以及需要灌肠/减轻不适）的得分显着提高（分别为P <0.01，P = 0.049，P = 0.03）。与对照组相比，DKT组的GVS也显着降低（P = 0.03）。除传统疗法外，DKT还可以有效治疗中风后患者的功能性便秘。该研究是一项随机对照试验，已在UMIN临床试验注册中心注册（编号UMIN000007393）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号